Balyasny Asset Management’s Elevance Health ELV Stock Holding History

Balyasny Asset Management’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-34,300	Closed	-$12M	–	3054
2025 Q4	$12M	Sell	34,300 -3,100	-8%	-$1.05M	0.02%	940
2025 Q3	$12.1M	Buy	37,400 +4,900	+15%	+$1.52M	0.02%	957
2025 Q2	$12.6M	Sell	32,500 -400	-1%	-$161K	0.02%	859
2025 Q1	$14.3M	Sell	32,900 -3,600	-10%	-$1.45M	0.02%	737
2024 Q4	$13.5M	Buy	36,500 +2,200	+6%	+$921K	0.02%	834
2024 Q3	$17.8M	Buy	34,300 +1,000	+3%	+$534K	0.03%	687
2024 Q2	$18M	Buy	33,300 +600	+2%	+$317K	0.03%	643
2024 Q1	$17M	Buy	32,700 +31,200	+2,080%	+$15.5M	0.03%	699
2023 Q4	$707K	Buy	+1,500	New	+$694K	﹤0.01%	1821
2021 Q3	–	Sell	-2,000	Closed	-$764K	–	2068
2021 Q2	$764K	Buy	+2,000	New	+$764K	﹤0.01%	1404

Other funds holding ELV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

Balyasny Asset Management's ELV Position: Q1 2026 in Review

Balyasny Asset Management increased its Elevance Health (ELV) stake by 1,346% in Q1 2026, buying an estimated $81.3M and bringing the position to 265,660 shares worth $77.8M. The position accounts for 0.1% of the portfolio, ranked #221.

Balyasny Asset Management first reported a position in ELV in Q4 2015 and has held it in 31 quarters since. The position peaked at $89.6M in Q2 2024. 1,464 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

Balyasny Asset Management held 265,660 shares of Elevance Health worth $77.8M as of Q1 2026.
Balyasny Asset Management bought 247,292 Elevance Health shares in Q1 2026, an estimated $81.3M.
Elevance Health made up 0.1% of Balyasny Asset Management's portfolio in Q1 2026, its #221 holding.
Balyasny Asset Management first reported a position in Elevance Health in Q4 2015 and has held it in 31 quarters since.
Balyasny Asset Management's Elevance Health position peaked at $89.6M in Q2 2024.
1,464 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on Balyasny Asset Management's 13F filing for Q1 2026, filed 15 May 2026.